---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-009798"
form_type: "8-K"
ticker: "GKOS"
cik: "0001192448"
company_name: "GLAUKOS Corp"
filed_at: "2025-07-30T23:59:59+00:00"
generated_at: "2026-05-17T22:51:03.609990+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Glaukos Q2 record net sales $124.1M (+30% YoY); raises FY 2025 guidance to $480-486M

## Summary
- Record net sales $124.1M, up 30% YoY; glaucoma sales $103.5M (+36%), U.S. glaucoma $72.3M (+45%).
- Net loss narrowed to $19.7M ($0.34 per share) from $50.5M ($1.00); non-GAAP loss $13.6M ($0.24).
- Gross margin ~78%, non-GAAP ~83%; cash & investments $278.6M, zero debt.
- Raised 2025 net sales guidance to $480-486M (prior $475-485M); management cites sustained growth acceleration.

## SEC filing metadata
- accession: 0001558370-25-009798
- form_type: 8-K
- ticker: GKOS
- cik: 0001192448
- company_name: GLAUKOS Corp
- filed_at: 2025-07-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1192448/000155837025009798/0001558370-25-009798-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1192448/000155837025009798/gkos-20250730x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-009798
- JSON: https://secwatch.observer/filing/0001558370-25-009798.json
- Plain text: https://secwatch.observer/filing/0001558370-25-009798.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.